The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
New criteria for sepsis-induced coagulopathy (SIC) following the revised sepsis definition: a retrospective analysis of a nationwide survey
Open accessAbstract
Objective: Recent clinical studies have shown that anticoagulant therapy might be effective only in specific at-risk subgroups of patients with sepsis and coagulation dysfunction. The definition of sepsis was recently modified, and as such, old scoring systems may no longer be appropriate for the diagnosis of sepsis-associated coagulopathy. The aim of this study was to evaluate prognostic factors in patients diagnosed with sepsis and coagulopathy according to the new sepsis definition and assess their accuracy in comparison with existing models. Design: Retrospective analysis of the nationwide survey for recombinant human soluble thrombomodulin. Setting: General emergency and critical care centres in secondary and tertiary care hospitals. Participants: We evaluated the prognostic value of the newly proposed diagnostic criteria for sepsis-induced coagulopathy (SIC). A total of 1498 Japanese patients with sepsis and coagulopathy complications who were treated with recombinant thrombomodulin were analysed in this study. Main outcome measures: The platelet count, prothrombin time (PT) ratio, fibrinogen/fibrin degradation products, systemic inflammatory response syndrome score and Sequential Organ Failure Assessment (SOFA) score obtained just before the start of treatment were examined in relation to the 28-day mortality rate. Results: The platelet count, PT ratio and total SOFA were independent predictors of a fatal outcome in a logistic regression model. A SIC score was defined using the three above-mentioned variables with a positivity threshold of 4 points or more. The SIC score predicted higher 28-day mortality rate compared with the current Japanese Association for Acute Medicine-disseminated intravascular coagulation score (38.4%vs34.7%). Conclusion: The SIC score is based on readily available parameters, is easy to calculate and has a high predictive value for 28-day mortality. Future studies are warranted to evaluate whether the SIC score may guide the decision to initiate anticoagulant therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The third international consensus definitions for sepsis and septic shock (Sepsis-3).
Singer, M., Deutschman, C. S., Seymour, C. W., Shankar-Hari, M., Annane, D., Bauer, M., Bellomo, R., Bernard, G. R., Chiche, J.-D., Coopersmith, C. M., et al. (2016) · JAMA · doi:10.1001/jama.2016.0287 · Cited by 28,250
Bone, R. C., Balk, R. A., Cerra, F. B., Dellinger, R. P., Fein, A. M., Knaus, W. A., Schein, R. M. H., & Sibbald, W. J. (1992) · Chest · doi:10.1378/chest.101.6.1644 · Cited by 13,198
Surviving Sepsis Campaign: International Guidelines for Management of Severe Sepsis and Septic Shock
Dellinger, R. P., Levy, M. M., Rhodes, A., Annane, D., Gerlach, H., Opal, S. M., Sevransky, J. E., Sprung, C. L., Douglas, I. S., Jaeschke, R., et al. (2013) · Critical Care Medicine · doi:10.1097/ccm.0b013e31827e83af · Cited by 9,694
The Surviving Sepsis Campaign Guidelines Committee including The Pediatric Subgroup*, Dellinger, R. P., Levy, M. M., Rhodes, A., Annane, D., Gerlach, H., Opal, S. M., Sevransky, J. E., Sprung, C. L., Douglas, I. S., et al. (2013) · Intensive Care Medicine · doi:10.1007/s00134-012-2769-8 · Cited by 7,290
Intravenous Fluids and Acute Kidney Injury
Ding, X., Cheng, Z., & Qian, Q. (2017) · Blood Purification · doi:10.1159/000452702 · Cited by 6,827
Hematological Problems in Pediatric Intensive Care
Revel-Vilk, S., Cox, P., Robitaille, N., & Blanchette, V. (2014) · Pediatric and Adolescent Medicine · doi:10.1159/000350346 · Cited by 3,508
Vincent, J.-L., de Mendonca, A., Cantraine, F., Moreno, R., Takala, J., Suter, P. M., Sprung, C. L., Colardyn, F., & Blecher, S. (1998) · Critical Care Medicine · doi:10.1097/00003246-199811000-00016 · Cited by 3,463
Taylor, F., Toh, C.-H., Hoots, K., Wada, H., & Levi, M. (2001) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1616068 · Cited by 2,285
Disseminated Intravascular Coagulation
Levi, M., & ten Cate, H. (1999) · New England Journal of Medicine · doi:10.1056/nejm199908193410807 · Cited by 2,005
High-Dose Antithrombin III in Severe Sepsis: A Randomized Controlled Trial
Warren, B. L., Eid, A., Singer, P., Pillay, S. S., Carl, P., Novak, I., Chalupa, P., Atherstone, A., Pénzes, I., Kübler, A., et al. (2001) · JAMA · doi:10.1001/jama.286.15.1869 · Cited by 1,419
Drotrecogin Alfa (Activated) in Adults with Septic Shock
Ranieri, V. M., Thompson, B. T., Barie, P. S., Dhainaut, J.-F., Douglas, I. S., Finfer, S., Gårdlund, B., Marshall, J. C., Rhodes, A., Artigas, A., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1202290 · Cited by 1,309
Seong, S.-Y., & Matzinger, P. (2004) · Nature Reviews Immunology · doi:10.1038/nri1372 · Cited by 1,220
Gando, S., Iba, T., Eguchi, Y., Ohtomo, Y., Okamoto, K., Koseki, K., Mayumi, T., Murata, A., Ikeda, T., Ishikura, H., et al. (2006) · Critical Care Medicine · doi:10.1097/01.ccm.0000202209.42491.38 · Cited by 647
Self-citationInflammation, endothelium, and coagulation in sepsis
Schouten, M., Wiersinga, W. J., Levi, M., & van der Poll, T. (2008) · Journal of Leukocyte Biology · doi:10.1189/jlb.0607373 · Cited by 629
Disseminated intravascular coagulation
Gando, S., Levi, M., & Toh, C.-H. (2016) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2016.37 · Cited by 572
KIENAST, J., JUERS, M., WIEDERMANN, C. J., HOFFMANN, J. N., OSTERMANN, H., STRAUSS, R., KEINECKE, H., WARREN, B. L., & OPAL, S. M. (2006) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2005.01697.x · Cited by 435
Dhainaut, J. ‐., Yan, S. B., Joyce, D. E., Pettilä, V., Basson, B., Brandt, J. T., Sundin, D. P., & Levi, M. (2004) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2004.00955.x · Cited by 426
Vincent, J.-L., Ramesh, M. K., Ernest, D., LaRosa, S. P., Pachl, J., Aikawa, N., Hoste, E., Levy, H., Hirman, J., Levi, M., et al. (2013) · Critical Care Medicine · doi:10.1097/ccm.0b013e31828e9b03 · Cited by 320
Kobayashi, N., Maekawa, T., Takada, M., Tanaka, H., & Gonmori, H. (2015) · Current Studies in Hematology and Blood Transfusion · doi:10.1159/000408467 · Cited by 309
Kadri, S. S., Rhee, C., Strich, J. R., Morales, M. K., Hohmann, S., Menchaca, J., Suffredini, A. F., Danner, R. L., & Klompas, M. (2017) · Chest · doi:10.1016/j.chest.2016.07.010 · Cited by 242
Umemura, Y., Yamakawa, K., Ogura, H., Yuhara, H., & Fujimi, S. (2016) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.13230 · Cited by 234
Innate immunity and coagulation
ESMON, C. T., XU, J., & LUPU, F. (2011) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2011.04323.x · Cited by 218
DAMP and DIC: The role of extracellular DNA and DNA-binding proteins in the pathogenesis of DIC
Liaw, P. C., Ito, T., Iba, T., Thachil, J., & Zeerleder, S. (2016) · Blood Reviews · doi:10.1016/j.blre.2015.12.004 · Cited by 181
Self-citationRecombinant human soluble thrombomodulin in severe sepsis: a systematic review and meta‐analysis
Yamakawa, K., Aihara, M., Ogura, H., Yuhara, H., Hamasaki, T., & Shimazu, T. (2015) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.12841 · Cited by 158
Benefit profile of anticoagulant therapy in sepsis: a nationwide multicentre registry in Japan
for the Japan Septic Disseminated Intravascular Coagulation (J-Septic DIC) study group, Yamakawa, K., Umemura, Y., Hayakawa, M., Kudo, D., Sanui, M., Takahashi, H., Yoshikawa, Y., Hamasaki, T., & Fujimi, S. (2016) · Critical Care · doi:10.1186/s13054-016-1415-1 · Cited by 140
Yamakawa, K., Ogura, H., Fujimi, S., Morikawa, M., Ogawa, Y., Mohri, T., Nakamori, Y., Inoue, Y., Kuwagata, Y., Tanaka, H., et al. (2013) · Intensive Care Medicine · doi:10.1007/s00134-013-2822-2 · Cited by 113
Yamakawa, K., Saito, S., Uchino, S., Kudo, D., Iizuka, Y., Sanui, M., Takimoto, K., Mayumi, T., Ono, K., Hayakawa, M., et al. (2016) · Thrombosis and Haemostasis · doi:10.1160/th15-12-0987 · Cited by 113
Disseminated intravascular coagulation: Testing and diagnosis
Wada, H., Matsumoto, T., Yamashita, Y., & Hatada, T. (2014) · Clinica Chimica Acta · doi:10.1016/j.cca.2014.04.020 · Cited by 76
Yoshimura, J., Yamakawa, K., Ogura, H., Umemura, Y., Takahashi, H., Morikawa, M., Inoue, Y., Fujimi, S., Tanaka, H., Hamasaki, T., et al. (2015) · Critical Care · doi:10.1186/s13054-015-0810-3 · Cited by 69
Mimuro, J., Takahashi, H., Kitajima, I., Tsuji, H., Eguchi, Y., Matsushita, T., Kuroda, T., & Sakata, Y. (2013) · Thrombosis Research · doi:10.1016/j.thromres.2013.03.008 · Cited by 50
What’s new in the diagnostic criteria of disseminated intravascular coagulation?
Gando, S., Meziani, F., & Levi, M. M. (2016) · Intensive Care Medicine · doi:10.1007/s00134-016-4257-z · Cited by 36
Cited by
Tang, N., Bai, H., Chen, X., Gong, J., Li, D., & Sun, Z. (2020) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.14817 · Cited by 3,559
ISTH interim guidance on recognition and management of coagulopathy in COVID‐19
Thachil, J., Tang, N., Gando, S., Falanga, A., Cattaneo, M., Levi, M., Clark, C., & Iba, T. (2020) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.14810 · Cited by 1,925
Self-citationDiagnosis and management of sepsis‐induced coagulopathy and disseminated intravascular coagulation
Iba, T., Levy, J. H., Warkentin, T. E., Thachil, J., van der Poll, T., & Levi, M. (2019) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.14578 · Cited by 531
Self-citationDifference of coagulation features between severe pneumonia induced by SARS-CoV2 and non-SARS-CoV2
Yin, S., Huang, M., Li, D., & Tang, N. (2021) · Journal of Thrombosis and Thrombolysis · doi:10.1007/s11239-020-02105-8 · Cited by 434
The versatile heparin in COVID-19
Thachil, J. (2020) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.14821 · Cited by 404
Self-citation
Metadata
- Authors
- Iba, T., Nisio, M. D., Levy, J. H., Kitamura, N., & Thachil, J.
- Venue
- BMJ Open
- Publisher
- BMJ
- Published
- 2017-09
- Volume
- 7
- Issue
- 9
- Pages
- e017046
- ISSN
- 2044-6055 (ISSN-L)
- OpenAlex
- W2745119542
- Cited by
- 426
- References
- 31
- FWCI
- 18.18
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.